[In patients with active cancer and venous thromboembolism who have been anticoagulated for at least 6 months, is extended treatment with a reduced dose of apixaban effective in preventing recurrences and reducing the risk of bleeding, compared to a full dose?]
Luc Lanthier, Geneviève Le Templier, Alexandre Mutchmore, Marc-Émile Plourde, Michel Cauchon
{"title":"[In patients with active cancer and venous thromboembolism who have been anticoagulated for at least 6 months, is extended treatment with a reduced dose of apixaban effective in preventing recurrences and reducing the risk of bleeding, compared to a full dose?]","authors":"Luc Lanthier, Geneviève Le Templier, Alexandre Mutchmore, Marc-Émile Plourde, Michel Cauchon","doi":"10.1016/j.revmed.2025.06.011","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":94122,"journal":{"name":"La Revue de medecine interne","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"La Revue de medecine interne","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.revmed.2025.06.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
